NCT04600388View on ClinicalTrials.gov

Efficacy and Safety of Nerivio for the Acute Treatment of Menstrual Migraine

CompletedOBSERVATIONAL
Enrollment

121

Participants

Timeline

Start Date

September 9, 2020

Primary Completion Date

November 1, 2020

Study Completion Date

November 10, 2020

Conditions
Menstrual Migraine
Interventions
DEVICE

Nerivio

Nerivio Remote Electrical Neuromodulation (REN) device

Trial Locations (1)

12601

Vassar Ambulatory Surgical Center, Poughkeepsie

Sponsors

Lead Sponsor

Theranica
All Listed Sponsors
lead

Theranica

INDUSTRY

NCT04600388 - Efficacy and Safety of Nerivio for the Acute Treatment of Menstrual Migraine | Biotech Hunter | Biotech Hunter